EMILY ERICKSON: Open Payments
NPI 1376776898 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,683 in 51 payments from 11 companies in 2025. Trend: 2023 $1,104 · 2024 $964 · 2025 $1,683
Food & beverage: $1,683
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $480 |
| Novartis Pharmaceuticals Corporation | 8 | $453 |
| UCB, Inc. | 6 | $246 |
| ABBVIE INC. | 14 | $168 |
| PFIZER INC. | 2 | $111 |
| Galderma Laboratories, L.P. | 3 | $74 |
| LEO Pharma Inc. | 1 | $68 |
| Lilly USA, LLC | 1 | $30 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $19 |
Products named: TREMFYA, Bimzelx, Rhapsido, SKYRIZI, COSENTYX, LITFULO, NEMLUVIO, ADBRY.
Industry payments across IA — which companies pay providers there.
